7 search results for: gina

<b>Gina</b> Mangin
Expert
Gina Mangin, MPAS, PA-C

Gina Mangin, MPAS, PA-C is a Physician Assistant at Sand Lake Dermatology Center in Orlando, Florida

Exploring IL-31–mediated immune modulation and the role of IL-4 signaling in AD-related conjunctivitis
Dermatology
Exploring IL-31–mediated immune modulation and the role of IL-4 signaling in AD-related conjunctivitis
expert video

Join Dr. Lisa Swanson and Gina Mangin discussing myths and perceptions on understanding IL-31's role in modulating immune responses and exploring a possible link between IL-4 inhibition and conjunctivitis in AD.

View more
Evaluating the cytokine hierarchy in AD and the contributions of IL-4, IL-13, and IL-31 to itch
Dermatology
Evaluating the cytokine hierarchy in AD and the contributions of IL-4, IL-13, and IL-31 to itch
expert video

Join Lisa Swanson, MD, and Gina Mangin, MPAS, PA-C as they discuss the evaluation of the cytokine hierarchy in AD and the contributions of IL-4, IL-13, and IL-31 to itch.

View more
Differential Roles of IL-4 and IL-13 in AD Pathogenesis and B Cell Activation
Dermatology
Differential Roles of IL-4 and IL-13 in AD Pathogenesis and B Cell Activation
expert video

This video features Dr. Lisa Swanson and Gina Mangin on the differential roles of IL-4 and IL-13 in atopic dermatitis pathogenesis and B-Cell activation at the Riptide conference on December 5, 2025.

View more
Atopic Dermatitis: Pathomechanisms: Clarifying Perspectives and Misconceptions
Dermatology
Atopic Dermatitis: Pathomechanisms: Clarifying Perspectives and Misconceptions
expert video

Join Lisa Swanson, MD, and Gina Mangin, MPAS, PA-C, for an in-depth discussion on the immunopathogenesis of atopic dermatitis (AD), highlighting the central role of key type 2 inflammatory pathways in disease development and progression. This program explores how these pathways contribute to clinical manifestations across the AD spectrum and addresses common perceptions and misconceptions surrounding AD pathomechanisms, offering clarifying insights to support informed clinical decision-making.

View more
ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?
Pulmonology
ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?
expert video

Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.

View more
ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?
On Demand
ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.